SNTSYNTARA LIMITED

AZALOX MDS study advances to final Phase 1b cohort

Date and time
Announcement type
Company Update
Show details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences